171 related articles for article (PubMed ID: 33640000)
1. Differences between primary peritoneal serous carcinoma and advanced serous ovarian carcinoma: a study based on the SEER database.
Li X; Yang Q; Chen M; Yang C; Gu J; Dong Q; Yang G
J Ovarian Res; 2021 Feb; 14(1):40. PubMed ID: 33640000
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of Prognostic Nomogram for Primary Peritoneal Serous Carcinoma Compared With FIGO Staging System: A Population-Based Study.
Chen M; Wen Z; Qi Z; Gao M
Front Oncol; 2021; 11():651969. PubMed ID: 34490079
[TBL] [Abstract][Full Text] [Related]
3. Precursor lesions and prognostic factors in primary peritoneal serous carcinoma.
Lee S; Nelson G; Duan Q; Magliocco AM; Duggan MA
Int J Gynecol Pathol; 2013 Nov; 32(6):547-55. PubMed ID: 24071870
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal papillary serous carcinoma: study of 15 cases and comparison with stage III-IV ovarian papillary serous carcinoma.
Piura B; Meirovitz M; Bartfeld M; Yanai-Inbar I; Cohen Y
J Surg Oncol; 1998 Jul; 68(3):173-8. PubMed ID: 9701210
[TBL] [Abstract][Full Text] [Related]
5. Stage IIIC ovarian/peritoneal serous carcinoma: a heterogeneous group of patients with different prognoses.
Bakkar R; Gershenson D; Fox P; Vu K; Zenali M; Silva E
Int J Gynecol Pathol; 2014 May; 33(3):302-8. PubMed ID: 24681743
[TBL] [Abstract][Full Text] [Related]
6. Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma.
Ben-Baruch G; Sivan E; Moran O; Rizel S; Menczer J; Seidman DS
Gynecol Oncol; 1996 Mar; 60(3):393-6. PubMed ID: 8774644
[TBL] [Abstract][Full Text] [Related]
7. Primary peritoneal serous carcinoma: a clinicopathological and immunohistochemical study of six cases.
Hou T; Liang D; He J; Chen X; Zhang Y
Int J Clin Exp Pathol; 2012; 5(8):762-9. PubMed ID: 23071858
[TBL] [Abstract][Full Text] [Related]
8. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for the treatment of primary peritoneal serous carcinoma: Results of a Chinese retrospective study.
Sun JH; Ji ZH; Peng KW; Wu HT; Zhang Q; Yonemura Y; Li Y
Int J Hyperthermia; 2016 May; 32(3):289-97. PubMed ID: 26982735
[TBL] [Abstract][Full Text] [Related]
9. The Prevalence, Associated Factors for Lung Metastases Development and Prognosis in Ovarian Serous Cancer Based on SEER Database.
Cao C; Yang X
Technol Cancer Res Treat; 2020; 19():1533033820983801. PubMed ID: 33356997
[TBL] [Abstract][Full Text] [Related]
10. Exploration and prognostic analysis of two types of high-risk ovarian cancers: clear cell vs. serous carcinoma: a population-based study.
Liu T; Gao Y; Li S; Xu S
J Ovarian Res; 2024 Jun; 17(1):119. PubMed ID: 38824600
[TBL] [Abstract][Full Text] [Related]
11. Primary peritoneal serous carcinoma treated by cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. A multi-institutional study of 36 patients.
Bakrin N; Gilly FN; Baratti D; Bereder JM; Quenet F; Lorimier G; Mohamed F; Elias D; Glehen O;
Eur J Surg Oncol; 2013 Jul; 39(7):742-7. PubMed ID: 23510853
[TBL] [Abstract][Full Text] [Related]
12. Primary Peritoneal Serous Carcinoma in Men: A Rare and Non-
Neuhausen SL; Shani H; Boker LK; Steele L; Silverman BG; Ottini L; Silvestri V; Laitman Y; Korach J; Perri T; Friedman E
Anticancer Res; 2017 Jun; 37(6):3069-3072. PubMed ID: 28551646
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy is not necessary for early-stage serous and endometrioid ovarian cancer after undergoing comprehensive staging surgery.
Li S; Zhu Z
J Ovarian Res; 2020 Aug; 13(1):91. PubMed ID: 32772926
[TBL] [Abstract][Full Text] [Related]
14. Poorer prognosis of ovarian squamous cell carcinoma than serous carcinoma: a propensity score matching analysis based on the SEER database.
Zhang C; Ma T
J Ovarian Res; 2020 Jul; 13(1):75. PubMed ID: 32611433
[TBL] [Abstract][Full Text] [Related]
15. [CA 125 regression after two cycles of neoadjuvant chemotherapy as prognostic factor in patients with advanced ovarian cancer and primary peritoneal serous cancer who underwent interval surgical cytoreduction].
Gasowska-Bodnar A; Bodnar L; Wcisło GB; Jerzak MM; Szczylik C; Baranowski W
Ginekol Pol; 2008 Feb; 79(2):108-14. PubMed ID: 18510089
[TBL] [Abstract][Full Text] [Related]
16. Primary peritoneal serous carcinoma: a primer for radiologists.
Gan J; Herzog J; Smith DA; Vos D; Kikano E; Tirumani SH; Ramaiya NH
Clin Imaging; 2022 Mar; 83():56-64. PubMed ID: 34974267
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of Transitional Cell Carcinoma-Like Morphology of High-Grade Serous Ovarian Carcinoma: A Comparative Study.
Nasioudis D; Sisti G; Kanninen TT; Fambrini M; Di Tommaso M
Int J Gynecol Cancer; 2016 Nov; 26(9):1624-1629. PubMed ID: 27575630
[TBL] [Abstract][Full Text] [Related]
18. Development and identification of a prognostic nomogram model for patients with mixed cell adenocarcinoma of the ovary.
Wu H; Jiang S; Zhong P; Li W; Zhang S
J Ovarian Res; 2021 Oct; 14(1):137. PubMed ID: 34674727
[TBL] [Abstract][Full Text] [Related]
19. High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma.
Cui X; Li L; Yan G; Meng K; Lin Z; Nan Y; Jin G; Li C
BMC Cancer; 2015 Apr; 15():244. PubMed ID: 25885439
[TBL] [Abstract][Full Text] [Related]
20. Prognosis comparison between small cell carcinoma of ovary and high-grade serous ovarian cancer: A retrospective observational cohort study.
Hu D; Ma D; Zhang ZJ; Zhang Y; Huang K; Li X
Front Endocrinol (Lausanne); 2023; 14():1103429. PubMed ID: 36742399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
